Cara Therapeutic Company Insiders

Cara Therapeutic Management Team Effectiveness

The company has return on total asset (ROA) of (0.6343) % which means that it has lost $0.6343 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8432) %, meaning that it created substantial loss on money invested by shareholders. Cara Therapeutic's management efficiency ratios could be used to measure how well Cara Therapeutic manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.89. The current year's Return On Capital Employed is expected to grow to -1.15. At present, Cara Therapeutic's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 1.6 M, whereas Non Current Assets Total are forecasted to decline to about 9.2 M. As of November 27, 2024, Common Stock Shares Outstanding is expected to decline to about 35.8 M. In addition to that, Net Loss is expected to decline to about (80.8 M)

Cara Therapeutic Workforce Comparison

Cara Therapeutic Insider Trading

Cara Therapeutic Notable Stakeholders

The success or failure of an entity such as Cara Therapeutic often depends on how effective the management is. Cara Therapeutic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cara management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cara management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Cara Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cara Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cara Therapeutic's management manipulating its earnings.

When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.